SEP
NUVL

Signature Equity Partners’s Nuvalent NUVL Stock Holding History

Signature Equity Partners’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$820 Buy
+8
New +$815 ﹤0.01% 1299

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Signature Equity Partners's NUVL Position: Q1 2026 in Review

Signature Equity Partners opened a new position in Nuvalent (NUVL) in Q1 2026: 8 shares worth $820. The stake represents ﹤0.01% of the portfolio and ranks #1299 among its holdings.

263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Signature Equity Partners held 8 shares of Nuvalent worth $820 as of Q1 2026.
  • Nuvalent was a new Signature Equity Partners position in Q1 2026.
  • Nuvalent made up ﹤0.01% of Signature Equity Partners's portfolio in Q1 2026, its #1299 holding.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Signature Equity Partners's 13F filing for Q1 2026, filed 13 May 2026.